Literature DB >> 12847709

Long-term outcome of etanercept therapy in children with treatment-refractory uveitis.

Andreas Reiff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12847709     DOI： 10.1002/art.11155

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  15 in total

Review 1.  Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease.

Authors:  Arnd Heiligenhaus; Stephan Thurau; Maren Hennig; Rafael S Grajewski; Gerhild Wildner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-25       Impact factor: 3.117

Review 2.  Management of sight-threatening uveitis: new therapeutic options.

Authors:  Matthias D Becker; Justine R Smith; Regina Max; Christoph Fiehn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis.

Authors:  Melissa A Lerman; C Egla Rabinovich
Journal:  Paediatr Drugs       Date:  2015-08       Impact factor: 3.022

4.  Adalimumab in the therapy of uveitis in childhood.

Authors:  Sabine Biester; Christoph Deuter; Hartmut Michels; Renate Haefner; Jasmin Kuemmerle-Deschner; Deshka Doycheva; Manfred Zierhut
Journal:  Br J Ophthalmol       Date:  2006-10-11       Impact factor: 4.638

Review 5.  Management of extraintestinal manifestations and other complications of inflammatory bowel disease.

Authors:  Edward V Loftus
Journal:  Curr Gastroenterol Rep       Date:  2004-12

Review 6.  [TNFalpha inhibitors in the treatment of uveitis].

Authors:  K Greiner; J Plskova
Journal:  Ophthalmologe       Date:  2005-04       Impact factor: 1.059

7.  Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up.

Authors:  Stacy P Ardoin; Deborah Kredich; Egla Rabinovich; Laura E Schanberg; Glenn J Jaffe
Journal:  Am J Ophthalmol       Date:  2007-10-22       Impact factor: 5.258

Review 8.  Judicious use of biologicals in juvenile idiopathic arthritis.

Authors:  Yongdong Zhao; Carol Wallace
Journal:  Curr Rheumatol Rep       Date:  2014-11       Impact factor: 4.592

Review 9.  Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review.

Authors:  Susan Shenoi; Carol A Wallace
Journal:  Paediatr Drugs       Date:  2010-12-01       Impact factor: 3.022

Review 10.  Systemic treatment of vitreous inflammation.

Authors:  John B Christoforidis; Susie Chang; Angela Jiang; Jillian Wang; Colleen M Cebulla
Journal:  Mediators Inflamm       Date:  2012-09-16       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.